Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H14FO3P |
Molecular Weight | 184.146 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OP(=O)(F)OC(C)C
InChI
InChIKey=MUCZHBLJLSDCSD-UHFFFAOYSA-N
InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3
Molecular Formula | C6H14FO3P |
Molecular Weight | 184.146 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/mmx/isoflurophate.html
Sources: https://www.drugs.com/mmx/isoflurophate.html
Isofluorophate (diisopropyl fluorophosphate) is an irreversile acetylcholinesterase inhibitor. It was used in ophthalmology as a miotic agent in treatment of chronic glaucoma.
Originator
Sources: http://www.fluoride-history.de/p-mfp.htm
Curator's Comment:: On Dec. 11th, 1941, Bernard Charles Saunders, University of Cambridge, UK, reported at a Ministry of Supply meeting in London the highly toxic nature of an ester of monofluorophosphoric acid, diisopropyl fluorophosphate (DFP), as a lethal inhalant.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20189400 |
6.0 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | FLOROPRYL Approved UseIsoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme. Launch Date-4.02364793E11 |
PubMed
Title | Date | PubMed |
---|---|---|
Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. | 2001 Dec |
|
Organophosphorus compounds alter intracellular F-actin content in SH-SY5Y human neuroblastoma cells. | 2001 Dec |
|
Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. | 2001 Winter |
|
A novel N(alpha)-acetyl alanine aminopeptidase from Allomyces arbuscula. | 2002 Apr |
|
Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. | 2002 Apr 15 |
|
Analysis of organophosphorus compound adducts of serine proteases by liquid chromatography-tandem mass spectrometry. | 2002 Aug 25 |
|
Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity. | 2002 Dec |
|
Deacylation of N-arylformamides and N-arylacetamides by formamidase in rat liver. | 2002 Dec |
|
A butyrylcholinesterase in the early development of the brine shrimp (Artemia salina) larvae: a target for phthalate ester embryotoxicity? | 2002 Dec 13 |
|
Rapid assessment of organophosphorous/carbamate exposure in the bivalve mollusc Mytilus edulis using combined esterase activities as biomarkers. | 2002 Dec 3 |
|
An antibody that binds to primary specific pocket-associated structure in the active site of bovine thrombin. | 2002 Feb |
|
Ionomycin-induced neutrophil NADPH oxidase activity is selectively inhibited by the serine protease inhibitor diisopropyl fluorophosphate. | 2002 Feb |
|
Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. | 2002 Feb 26 |
|
Purification and some properties of a keratinolytic enzyme from an alkaliphilic Nocardiopsis sp. TOA-1. | 2002 Jan |
|
Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant. | 2002 Jan |
|
Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. | 2002 Jul |
|
Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis. | 2002 Jul |
|
Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase. | 2002 Jul |
|
Purification and characterization of an esterase from Acinetobacter lwoffii I6C-1. | 2002 Jun |
|
Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. | 2002 Jun 15 |
|
Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs. | 2002 Jun 15 |
|
Nanocrystalline metal oxides as destructive adsorbents for organophosphorus compounds at ambient temperatures. | 2002 Jun 3 |
|
Early differential elevation and persistence of phosphorylated cAMP-response element binding protein (p-CREB) in the central nervous system of hens treated with diisopropyl phosphorofluoridate, an OPIDN-causing compound. | 2002 Mar |
|
Functional proteomics using microchannel plate detectors. | 2002 Mar |
|
EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity. | 2002 Mar |
|
Dipeptidyl peptidase with strict substrate specificity of an anaerobic periodontopathogen Porphyromonas gingivalis. | 2002 Mar 19 |
|
Purification and characterization of a collagenolytic protease from the filefish, Novoden modestrus. | 2002 Mar 31 |
|
[Amylases of the fungus Aspergillus flavipes associated with Fucus evanescens]. | 2002 Mar-Apr |
|
Sulfur mustard-stimulated protease: a target for antivesicant drugs. | 2002 Mar-Apr |
|
Degradation of glyceraldehyde-3-phosphate dehydrogenase induced by acetylleucine chloromethyl ketone in U937 cells. | 2002 May 15 |
|
Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. | 2002 May 15 |
|
Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. | 2002 May 17 |
|
Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile. | 2002 May 24 |
|
Production of interleukin-1 activity of Kupffer cells from mice treated with the acidic mannan fraction of baker's yeast. | 2002 Nov |
|
Characterization of the receptor-destroying enzyme activity from infectious salmon anaemia virus. | 2002 Nov |
|
The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus. | 2002 Nov 15 |
|
A mechanism-based probe for gp120-Hydrolyzing antibodies. | 2002 Nov 4 |
|
Atomic resolution crystal structure of squid ganglion DFPase. | 2002 Oct |
|
Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. | 2002 Sep |
|
Identification of two cysteine residues involved in the binding of UDP-GalNAc to UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1). | 2002 Sep |
|
High-activity enzyme-polyurethane coatings. | 2002 Sep 30 |
|
Gulf War related exposure factors influencing topical absorption of 14C-permethrin. | 2002 Sep 5 |
|
Purification and characterization of PrbA, a new esterase from Enterobacter cloacae hydrolyzing the esters of 4-hydroxybenzoic acid (parabens). | 2003 Apr 11 |
|
AMPA receptor potentiation by acetylcholinesterase is age-dependently upregulated at synaptogenesis sites of the rat brain. | 2003 Feb |
|
Influence of gender on thermoregulation and cholinesterase inhibition in the long-evans rat exposed to diazinon. | 2003 Feb 14 |
|
Structural and enzymatic characterization of physarolisin (formerly physaropepsin) proves that it is a unique serine-carboxyl proteinase. | 2003 Feb 21 |
|
Chlorophyllase as a serine hydrolase: identification of a putative catalytic triad. | 2003 Jan |
|
Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. | 2003 Jan 28 |
|
Lesions of rat skeletal muscle after local block of acetylcholinesterase and neuromuscular stimulation. | 2003 Jun |
|
The cholinesterase inhibitor DFP facilitates the expression of paradoxical sleep (PS) propensity in rats subjected to short-term PS deprivation. | 2003 Mar 7 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/mmx/isoflurophate.html
Topical, to the conjunctiva, a thin strip (approximately 0.5 cm) of a 0.025% ointment once every three days to three times a day.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20189400
Recombinant AChE was quantitated using the extinction coefficient 119, 650 M-1 cm-1 calculated from its amino acid sequence. AChE (34 nM) was assayed using Ellman’s reagent using 160 uM acetylthiocholine and 300 uM 5,50-dithiobis-2-ntirobenzoic acid (DTNB). Thiocholine released by the enzyme reacts with excess DTNB, resulting in the formation of the thionitrobenzoate anion, which absorbs at 412 nm. To assess IC50, the inhibitors were solubilized in isopropanol and used in volumes of less than 5% of the total reaction volume. AChE (34 nM) was incubated for 30 min with each compound at an array of concentrations. The residual activity of the enzyme was assayed using 500 uM acetylthiocholine, a saturating concentration 10-fold higher than the Km of 46 uM for this substrate.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Jun 25 21:53:44 UTC 2021
by
admin
on
Fri Jun 25 21:53:44 UTC 2021
|
Record UNII |
12UHW9R67N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47792
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
||
|
EPA PESTICIDE CODE |
356100
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
||
|
WHO-ATC |
S01EB07
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
55-91-4
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
55-91-4
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
CHEMBL1025
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
DIISOPROPYL FLUOROPHOSPHATE
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
1494
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
12UHW9R67N
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
6027
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | RxNorm | ||
|
DB00677
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
200-247-6
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
M6492
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | Merck Index | ||
|
D007531
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
SUB14274MIG
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
2133
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
5936
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY | |||
|
C65979
Created by
admin on Fri Jun 25 21:53:45 UTC 2021 , Edited by admin on Fri Jun 25 21:53:45 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |